- Home
- GOODN vs CERT Comparison
GOODN vs CERT Comparison
Compare GOODN & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOODN
- CERT
- Stock Information
- Founded
- GOODN N/A
- CERT 2008
- Country
- GOODN United States
- CERT United States
- Employees
- GOODN 69
- CERT N/A
- Industry
- GOODN Real Estate
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- GOODN Real Estate
- CERT Technology
- Exchange
- GOODN Nasdaq
- CERT Nasdaq
- Market Cap
- GOODN N/A
- CERT 1.9B
- IPO Year
- GOODN N/A
- CERT 2020
- Fundamental
- Price
- GOODN $22.04
- CERT $10.71
- Analyst Decision
- GOODN
- CERT Buy
- Analyst Count
- GOODN 0
- CERT 7
- Target Price
- GOODN N/A
- CERT $15.92
- AVG Volume (30 Days)
- GOODN N/A
- CERT 1.5M
- Earning Date
- GOODN N/A
- CERT 11-06-2024
- Dividend Yield
- GOODN N/A
- CERT N/A
- EPS Growth
- GOODN N/A
- CERT N/A
- EPS
- GOODN N/A
- CERT N/A
- Revenue
- GOODN N/A
- CERT $372,797,000.00
- Revenue This Year
- GOODN N/A
- CERT $10.20
- Revenue Next Year
- GOODN N/A
- CERT $10.01
- P/E Ratio
- GOODN N/A
- CERT N/A
- Revenue Growth
- GOODN N/A
- CERT 5.62
- 52 Week Low
- GOODN N/A
- CERT $9.41
- 52 Week High
- GOODN N/A
- CERT $19.87
- Technical
- Relative Strength Index (RSI)
- GOODN 20.24
- CERT 45.72
- Support Level
- GOODN $21.97
- CERT $10.31
- Resistance Level
- GOODN $22.64
- CERT $11.77
- Average True Range (ATR)
- GOODN 0.44
- CERT 0.58
- MACD
- GOODN -0.22
- CERT -0.07
- Stochastic Oscillator
- GOODN 11.46
- CERT 26.32
About GOODN Gladstone Commercial Corporation
Gladstone Commercial Corp is a real estate investment trust, which engages in investing and owning net leased industrial, commercial, and retail real property and making long-term industrial and commercial mortgage loans. Its portfolio consists of single-tenant commercial, industrial real properties, and medical properties nationwide. Its principal investment objectives are to generate income from rental properties.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.